Stock comparison

BSXvsSYK

Boston Scientific CorpvsStryker Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

BSX

Boston Scientific Corp

$64.87

-29.93%

Health Care$91.9BNYSE

SYK

Stryker Corp

$329.65

-6.27%

Health Care$125.4BNYSE

60-day price, rebased to 100

BSX -30.83% · SYK -10.80%

Round-by-round

BSX 3·SYK 3

EdgeBSX

Valuation upside

-27.90% vs -33.60% to DCF fair value

EdgeSYK

Balance-sheet strength

Altman Z 3.90 vs 4.61

EdgeBSX

Fundamental quality

Piotroski 9.00 vs 5.00 (of 9)

EdgeBSX

Growth + margins

Rule-of-40 36.80 vs 28.20

EdgeSYK

60-day momentum

-30.83% vs -10.80% price return

EdgeSYK

Market-cap liquidity

$91.9B vs $125.4B

Verdict

Across6categories,the two names are evenly matched —3wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onBSXorSYK

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.